Eli Lilly’s New GLP-1 Pill Posts Better-Than-Expected Results
The experimental drug, orforglipron, led to weight loss of nearly 8 percent at the highest dose, besting Wall Street expectations and sending Lilly’s shares up.

Mar 5, 2025 0
Mar 5, 2025 0
Mar 5, 2025 0
Mar 5, 2025 0
Apr 19, 2025 0
Apr 18, 2025 0
Apr 18, 2025 0
Apr 18, 2025 0
Or register with email
Feb 16, 2025 0
Feb 20, 2025 0
Feb 13, 2025 0
Mar 1, 2025 0
Feb 20, 2025 0